2023 年 4 月 4 日南昌大学第二附属医院口腔医学诊疗中心颌面外科完成江西省首例机器人辅助下舌 根恶性肿瘤扩大切除术。总手术时长62 min。患者术后生命体征平稳，吞咽功能恢复正常。于术后第3 d拔除气管插管， 第 5 d 拔除尿管。术后第 8 d 拔除胃管并恢复饮食。病理结果提示高分化舌鳞状细胞癌，（1/17）枚淋巴结见肿瘤转移。 术后复查血常规及生化全项检查均未见明显异常。目前患者恢复良好予以出院，总住院时长 21 d。

On April 4, 2023, the first case of robot-assisted enlarged resection of malignant tumor on the root of tongue in Jiangxi Province was performed by the Department of Maxillofacial Surgery of the Oral Medicine Centre of the Second Affiliated Hospital of Nanchang University, with a total operative time of 62 min. The patient’s general vital signs were stable and the swallowing function recovered well after surgery. The tracheal tube was removed on the 3rd d after surgery, the urinary catheter was removed on the 5th d, the gastric tube was removed on the 8th day, and the patient return to normal diet on the 8th day. Postoperative pathological findings confirmed highly differentiated squamous cell carcinoma of the tongue, and metastasis was seen in (1/17) lymph nodes. No abnormal results were found in routine postoperative blood tests and biochemical tests. The patient is now recovered well and discharged from hospital with the length of hospital stay of 21 d.

收稿日期：2023-04-25  录用日期：2023-05-18 Received Date: 2023-04-25  Accepted Date: 2023-05-18 基金项目：江西省重点研发计划一般项目（20192BBG70023）；江西省科技厅重点研发计划项目（20212BBG73006） Foundation Item: General Program of Key R&D Plan in Jiangxi Province(20192BBG70023); Key R&D Plan Program of Department of Science and Technology of Jiangxi Province(20212BBG73006) 通讯作者：宋莉，ndefy91009@ncu.edu.cn；王军，Email：273495280@qq.com Corresponding Author: SONG LI, Email: ndefy91009@ncu.edu.cn; WANG Jun, Email: 273495280@qq.com 引用格式：张若雁，杨羽晨，钟庐云，等 . 机器人辅助下舌根恶性肿瘤扩大切除术：江西省首例报道（附视频）[J]. 机器人外科学 杂志（中英文），2024，5（2）：254-258. Citation: ZHANG R Y, YANG Y C, ZHONG L Y, et al. Robot-assisted enlarged resection of malignant tumor of tongue root: the first case report in Jiangxi Province (with video)[J]. Chinese Journal of Robotic Surgery, 2024, 5(2): 254-258. 注：张若雁，杨羽晨为共同第一作者 Co-first Author: ZHANG Ruoyan, YANG Yuchen

[1] Siegel R L, Miller K D, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30. 

[2] 叶璞 , 黄兴鸿 , 张伟 , 等 . cN0 期舌鳞癌患者颈淋巴 结转移的相关因素及预后分析 [J]. 上海口腔医学 , 2022, 31(5): 540-543. 

[3] 席庆 , 张明 , 冯琳 , 等 . 9 例经口入路机器人手术 在口腔颌面外科应用报道 [J]. 中国口腔颌面外科杂 志 , 2020, 18(4): 365-368. 

[4] 孟令照 , 房居高 , 王建宏 , 等 . 达芬奇机器人经口 切除喉及下咽肿瘤的初步经验 [J]. 临床耳鼻咽喉头 颈外科杂志 , 2018, 32(14): 1065-1070. 

[5] Helman S N, Schwedhelm T, Kadakia S, et al. Transoral Robotic Surgery in Oropharyngeal Carcinoma[J]. Archives of Pathology & Laboratory Medicine, 2015, 139(11): 1389-1397. 

[6] Machiels J P, Leemans C R, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Annals of Oncology, 2020, 31(11): 1462-1475. 

[7] Mclean T, Fitzgerald C, Boyle J O. Therapeutic strategies: surgery for human papillomavirus-associated oropharyngeal carcinoma[J]. J Surg Oncol, 2021, 124(6): 935-944. 

[8] Nichols A C, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial[J]. The Lancet Oncology, 2019, 20(10): 1349-1359. 

[9] Haughey B H, Hinni M L, Salassa J R, et al. Transoral laser microsurgery as primary treatment for advancedstage oropharyngeal cancer: a united states multicenter study[J]. Head Neck, 2011, 33(12): 1683-1694. 

[10] Vicini C, Leone C A, Montevecchi F, et al. Successful application of transoral robotic surgery in failures of traditional transoral laser microsurgery: critical considerations[J]. ORL, 2014, 76(2): 98-104. 

[11] Nguyen A T, Luu M, Mallen-St Clair J, et al. Comparison of survival after transoral robotic surgery vs nonrobotic surgery in patients with early-stage oropharyngeal squamous cell carcinoma[J]. JAMA Oncol, 2020, 6(10): 1555. 

[12] Weinstein G S, O’Malley B W, Magnuson J S, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins[J]. The Laryngoscope, 2012, 122(8): 1701-1707. 

[13] Cracchiolo J R, Baxi S S, Morris L G, et al. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base: Increase in Primary Surgery for T1-T2 OPSCC[J]. Cancer, 2016, 122(10): 1523-1532. 

[14] Yom S S. The Tonsillar Fossa Battleground[J]. International Journal of Radiation Oncology*Biology* Physics, 2017, 97(1): 1-2. 

[15] Yeh D H, Tam S, Fung K, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma-A systematic review of the literature[J]. Eur J Surg Oncol, 2015, 41(12): 1603-1614.